Well... this is a contested topic, I suppose.

I'm on the total opposite side of the debate. IMO, the IPO should never have been granted in the first place. Moderna and others had their risks covered, their opportunities guaranteed, exceptional liability limitations, expedited approval of their product, and a whole lot of other benefits. That's all appropriate, but treating this as private IP is not.

Meanwhile, I'm amazed to see international IP recognition hold. US governance is one hell of a stick, it seems.

Can't say I understand the role of the WHO, but if they give cover to some much needed IP dissonance, I'm pro.

"Weaponizing a company's goodwill" seems like a ludicrous, to me. If the will is good, who does this violate anything? The fact that IP concerns are holding up production is a crime. I mean that literally. I would convict.